Serum copper associated with increased risk of cardiovascular disease in men

Written By :  Dr. Kamal Kant Kohli
Published On 2023-07-21 06:00 GMT   |   Update On 2023-07-21 10:45 GMT

Spain: Certain trace elements have been linked with an increased cardiovascular (CV) risk. A recent study has revealed a significant association between serum copper (S-Cu) levels and an increased risk of a first event of CVD (cardiovascular disease) in older Spanish men with high CV risk.The researchers stated that the risk of a first event if CVD was still within the reference values. "There...

Login or Register to read the full article

Spain: Certain trace elements have been linked with an increased cardiovascular (CV) risk. A recent study has revealed a significant association between serum copper (S-Cu) levels and an increased risk of a first event of CVD (cardiovascular disease) in older Spanish men with high CV risk.

The researchers stated that the risk of a first event if CVD was still within the reference values.

"There is a need for further studies to confirm this relationship and to analyse the differences observed between women and men," they wrote in their study published in Nutrition, Metabolism and Cardiovascular Diseases.

Ischemic heart disease and stroke are reported to be the first and second leading causes of death in people over 50 years of age, and there has been a worldwide increase in the burden of disease attributed to cardiovascular pathology. Therefore, it is appropriate to identify new modifiable risk factors that can improve the effectiveness of primary prevention measures for CVD. There has been an increase in interest in the effect of different trace elements, metals, and minerals on CVD.

Although the body's requirement for copper is lower than other metals, minerals, and trace elements, it is still crucial for many biological functions. However, a disorder of copper metabolism can contribute to the development of different pathologies, such as cancer, CVD, and neurodegenerative disease.

The study was conducted as a case-control study nested within the PREDIMED trial by Carlos Muñoz-Bravo, University of Málaga, Málaga, Spain, and colleagues. They aimed to evaluate the association between serum copper levels and the risk of the first event of CVD in a population of older adults with high cardiovascular risk.

A total of 207 incident cases diagnosed with cardiovascular disease were matched for age, sex and intervention group with 436 controls, during a median follow-up of 4.8 years. Known CVD risk factors were assessed using validated questionnaires, reviews of medical records, and personal interviews.

An annual collection was made of biological serum samples. Serum copper was determined using inductively coupled plasma mass spectrometry analysis. Adjusted odds ratios were determined using multivariate conditional logistic regression models.

The authors reported the following findings:

  • All participants had S-Cu levels within the reference values, 750 μg/L to 1450 μg/L.
  • Among men, but not among women, the mean S-Cu concentration was higher in cases at 1014.1 μg/L than in controls at 959.3 μg/L.
  • In men, the multivariable-adjusted odds ratio for CVD was 2.36, in women, it was 0.43.
  • An inverse association was observed between fruit and fish consumption and serum copper levels.

"We found an association between serum copper and an increased risk of cardiovascular disease in men," the researchers wrote.

"Our findings suggest a sex difference in cardiovascular disease risk and S-Cu levels. To confirm this relationship and to analyse the differences observed between men and women, there is a need for further studies," they concluded.

Reference:

Muñoz-Bravo C, Olmedo P, Gil F, Ruiz-Canela M, Martínez-González MA, Martínez MÁ, Babio N, Fitó M, del Val JL, Corella D, Sorlí JV, Ros E, Fiol M, Estruch R, Santos-Lozano JM, Arós F, Serra-Majem L, Pintó X, Gómez-Gracia E, Gutiérrez-Bedmar M, Association between serum copper levels and risk of cardiovascular disease: a nested case-control study in the PREDIMED trial, Nutrition, Metabolism and Cardiovascular Diseases, https://doi.org/10.1016/j.numecd.2023.07.008.


Tags:    
Article Source : Nutrition Metabolism and Cardiovascular Diseases

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News